Healthcare -
Biotechnology - NASDAQ - US
$ 572.78
-0.117 %
$ 61.6 B
Market Cap
14.93
P/E
REGN - TOTAL RECEIVABLES
Total Receivables REGN - Regeneron Pharmaceuticals, Inc.
6.21 B
LAST VALUE
7.97%
2 YEAR CAGR
24.22%
5 YEAR CAGR
20.33%
10 YEAR CAGR